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communication-focused therapy for
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Kristelle Hudry4, Kathy Leadbitter5, Ann Le Couteur6, Helen McConachie6, Andrew Pickles7, Vicky Slonims8,
Kathryn J. Temple6, Jonathan Green9 and the PACT Consortium
Abstract
Background: Autism is associated with impairments that have life-time consequences for diagnosed individuals
and a substantial impact on families. There is growing interest in early interventions for children with autism, yet
despite the substantial economic burden, there is little evidence of the cost-effectiveness of such interventions with
which to support resource allocation decisions. This study reports an economic evaluation of a parent-mediated,
communication-focused therapy carried out within the Pre-School Autism Communication Trial (PACT).
Methods: 152 pre-school children with autism were randomly assigned to treatment as usual (TAU) or PACT + TAU.
Primary outcome was severity of autism symptoms at 13-month follow-up. Economic data included health, education
and social services, childcare, parental productivity losses and informal care.
Results: Clinically meaningful symptom improvement was evident for 53 % of PACT + TAU versus 41 % of TAU (odds
ratio 1.91, p = 0.074). Service costs were significantly higher for PACT + TAU (mean difference £4,489, p < 0.001), but the
difference in societal costs was smaller and non-significant (mean difference £1,385, p = 0.788) due to lower informal
care rates for PACT + TAU.
Conclusions: Improvements in outcome generated by PACT come at a cost. Although this cost is lower when burden
on parents is included, the cost and effectiveness results presented do not support the cost-effectiveness of PACT +
TAU compared to TAU alone.
Trial registration: Current Controlled Trials ISRCTN58133827
Keywords: Autism, Economic evaluation, Cost-effectiveness, Pre-school, Communication
Background
Autism is a severe neurodevelopmental disability associ-
ated with impairments that have life-time consequences
for the health and quality of life of diagnosed individuals
[1] and a substantial impact on families [2]. The annual
cost of supporting children with autism spectrum disor-
ders in the UK has been estimated at between £3.1 and
£3.4 billion, dependent on the estimated proportion with
intellectual disability. Almost 50 % of the estimated costs
were accounted for by special education, including early
intervention services, with parental productivity losses
and respite care accounting for approximately 15 %
each. Medical services accounted for only 10 % of the
total [2].
There is growing interest in early interventions for
children with autism, [3, 4], yet despite the substantial
economic burden, there is little evidence of the cost-
effectiveness of such interventions with which to support
resource allocation decisions [5, 6]. Without such evi-
dence, it is impossible to determine whether the
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resources currently spent on interventions for children
with autism represent good value for money, or whether
greater benefits for children could be generated by
spending the money in other ways.
A number of cost-savings analyses of early intensive
behavioural interventions (EIBI) for children with autism
have been undertaken, which generally suggest initial ex-
penditure on EIBI would be more than offset by subse-
quent cost-savings over the long-term, primarily in
education and health care [7–10]. However, no full eco-
nomic evaluations, involving a formal assessment of
both costs and patient benefits in a comparative analysis
of two or more alternative interventions for children
with autism have been conducted.
This paper reports the results of an economic evaluation
of a pre-school intervention for children with autism carried
out within a multi-centre, randomised controlled trial – the
Pre-school Autism Communication Trial (PACT) [11]. The
CONSORT 2010 randomised trial checklist for the PACT
trial is reported in Additional File 1.
Methods
Hypothesis
The PACT trial compared the PACT intervention plus
treatment as usual (TAU) with TAU alone for pre-school
children with autism [11]. The economic hypothesis was
that the additional costs of PACT would be offset by im-
provements in patient outcomes and/or savings in the
use of other services, compared with TAU alone.
Trial design and participants
Families with a child aged 2 years to 4 years 11 months
meeting criteria for autism were recruited to a parallel
randomised controlled trial with one-to-one allocation
from specialist centres in London, Manchester and
Newcastle, UK, between September 2006 and February
2008. Autism was defined according to international
standard diagnostic tests, which include meeting criteria
on the social and communication domains and algo-
rithm total of the Autism Diagnostic Observation
Schedule-Generic (ADOS-G) [12] and on two of three
algorithm domains of the Autism Diagnostic Interview
Revised [13]. Exclusion criteria included children with a
twin with autism; a nonverbal age equivalent to
12 months or younger on the Mullen Early Learning
Scales [14]; epilepsy requiring medication; severe hearing
or visual impairment in a parent or the child; or a parent
with a severe psychiatric disorder requiring treatment.
Randomisation and masking
After consent was obtained and baseline assessments
were carried out by trial research assessors, the PACT
manager allocated a sequential identification number
and provided a statistician at the independent Christie
Clinical Trials Unit in Manchester with the child’s
number, treatment centre, age and autism severity. This
statistician ran an allocation schedule that was
computer-generated by use of probabilistic minimisation
of imbalance in the marginal distribution of treatment
centre, age (≤42 months or >42 months), and autism se-
verity (ADOS-G algorithm score 12–17 or 18–24). The
statistician then telephoned the treatment allocation to
the trial manager, who informed clinical sites. Research
assessors and supervising staff were blind to treatment
allocation but allocation could not be masked from ther-
apists or families. The study was approved by the Man-
chester Multicentre Research Ethics Committee and was
conducted in accordance with the ethical standards de-
fined in the 1964 Declaration of Helsinki and its later
amendments; at least one parent of each child provided
written consent.
Interventions
The PACT therapy was a developmental oriented,
parent-directed and video-aided intervention that was
moderated and matched to parental style. The interven-
tion targeted social interactive and communication im-
pairments in autism and was delivered by specially
trained speech and language therapists [11]. The trial
had six treatment therapists, two at each site and 3 lead
therapists, one at each site. The lead therapist provided
weekly supervision on case management and setting ap-
propriate targets for treatment therapists.
The rationale of the intervention was that children
would respond with enhanced communicative and social
development to a style of parent communication
adapted to their impairments. The aim was to increase
parental sensitivity and responsiveness to child commu-
nication and reduce mistimed parental responses by
working with the parent and using video-feedback
methods to address parent–child interaction. Further in-
cremental development of the child’s communication
was helped by promotion of a range of strategies such as
action routines, familiar repetitive language, and pauses.
The intervention consisted of an assessment session
followed by fortnightly one-to-one clinic sessions for six
months. Each session lasted approximately two and a
half hours and was conducted between therapist and
parent with the child present. This was followed by
monthly booster sessions for six months (up to a max-
imum 19 sessions including the assessment session). Be-
tween sessions, families were asked to do 30 min of daily
home practice. Clinic sessions were videotaped and 44
of these (with 37 participants), were selected by stratified
randomisation to balance therapist and treatment stage,
in order to assess treatment fidelity. Videos were
double-coded for therapist fidelity against 14 criteria by
PH, ALC and JG. Fidelity was demonstrated with a
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median of 13.4 criteria being met (inter-quartile range
12.5 to 14.0) per session.
The intervention was manualised and staged to repre-
sent the typical developmental progression of prelinguis-
tic and early language skills. Stages were as follows:
Stage 1 Establishing shared attention; Stage 2 Synchron-
icity and sensitivity; Stage 3 Focusing on language input;
Stage 4 Establishing routines and anticipation; Stage 5
Increasing communication functions; Stage 6 Expanding
language and conversations. Each stage had a specific
aim and strategies that the therapist targeted with the
parent. The intervention always started at Stage 1 with
at least 2–3 sessions focussing on this stage. Subsequent
progression was determined by the child’s developmental
readiness and the pace of the parent in working through
the goals. The intervention had measurable criteria for
moving from one stage to the next that enabled the ther-
apist to judge if the parent and child had accomplished a
level of skill at that particular stage. Children remained
at different stages for different periods of time and not
all children accomplished the higher stages 5 or 6.
Full details of the background to the PACT interven-
tion, and the development, principles, aims, trial proced-
ure and stages of the PACT intervention can be found
in the web appendix to the PACT clinical paper. For
more on the PACT trial protocol, please see
www.bbmh.manchester.ac.uk/pact.
Families in both groups continued with TAU provided
by local services, which commonly includes paediatri-
cians and speech and language therapists, alongside a
variety of other health, social care and education-based
services [6].
Clinical outcomes
Outcomes were assessed at baseline, 7 and 13-months
after randomisation. The primary outcome was severity
of autism symptoms measured using the ADOS-G social
communication algorithm score [12], researcher assessed
in interview with parents and modified to improve sensi-
tivity to change in children with no spoken words at
baseline [11]. The ADOS-G has cut-off points for autism
and autism spectrum disorder. Higher scores indicate
greater severity. Secondary measures included video-
rated, parent–child interaction during naturalistic play
(proportion of parental responses that were synchron-
ous, proportion of child communication with the parent
that were initiations and proportion of time spent in
mutual shared attention) [11], child language and social
communication using the researcher assessed Preschool
Language Scales [15], and adaptive functioning in school
using the Vineland Adaptive Behaviour Scales, Teacher
Rating Form [16], rated at endpoint by face-to-face
interview with teachers in nurseries, reception class, or
other appropriate carer who was not a member of the
family. Full details of the primary and secondary out-
comes measured in the PACT trial can be found in the
previously published clinical paper [11].
Resource use and cost
The economic evaluation took two cost perspectives:
1) a service perspective of particular interest to public
sector policy-makers, including all hospital, commu-
nity and school-based health, social and education
services, and 2) a societal perspective to capture the
full economic implications, which additionally in-
cluded schooling and childcare costs, parental out-of-
pocket expenditure (aids and adaptations to the
home, training courses etc.), productivity losses (time
off work due to child’s autism) and informal (unpaid)
care. For informal care, parents were asked to esti-
mate the additional hours of care they provide to
their child on an average day over and above what
they would provide for a child without autism, sepa-
rated into the following categories: personal care,
transport, housework and shopping, interacting/socia-
lising/playing and night-time supervision.
Data on all the service use and other resource use as-
sociated with these two perspectives were collected
using the Child and Adolescent Service Use Schedule
(CA-SUS) and the Carer Service Use Schedule (CARER-
SUS), designed in previous research with young people
[17, 18]. Both schedules were adapted for the purpose of
this study using expert opinion and pilot testing [6].
Data were collected in interview with parents at baseline
(covering the previous six months) and 7 and 13-month
follow-up (covering the period since last interview). Data
on use of the PACT intervention were collected from
therapist records. Details of other (non-PACT) speech
and language therapy were collected by trial therapists
from NHS speech and language therapists.
All resources used were then costed by applying unit
costs, in UK pounds sterling, for the financial year
2006–2007. Intervention sessions were costed on the
basis of the salary of the PACT therapists and any pro-
fessional assistance required. A cost per-hour was calcu-
lated including employer costs (National Insurance and
superannuation contributions), overheads (capital, ad-
ministrative and managerial) [19] and supervisor costs.
Indirect time (supervision, training, preparation, etc.)
was estimated using information provided by trial thera-
pists on the ratio of time spent in face-to-face contact to
time spent on other activities. Travel costs to home
visits were included.
Other unit costs were obtained from published sources
[19–21], national surveys [22], mainstream retailers of
non-prescription drugs, and government departments
for school costs. Productivity losses were calculated
using the human capital approach, which involves
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multiplying time off work due to the child’s illness by
the parent’s salary [23]. Informal care costs were calcu-
lated using the market price approach, which applies the
price that would be paid if the care were provided by a
formal caregiver [24], in this instance the cost of a home
care worker was used [19].
Statistical analysis
PACT was powered on the basis of a clinically meaning-
ful improvement in ADOS-G score between baseline
and follow up of ≥4 points; modelled as equivalent to a
7 month increase in age-equivalent adaptive functioning
[11]. Target recruitment was 144 families, and was calcu-
lated on the basis of a pilot study effect size for ADOS-
G of 0 · 92 [25] and allowing for 10 % attrition, to pro-
vide greater than 99 %, 98 %, 90 %, and 75 % power for
effect sizes of 0 · 8 SD (reduction of about 4 · 0 points),
0 · 6 SD (reduction of about 3 · 0 points), 0 · 5 SD (reduc-
tion of about 2 · 5 points), and 0 · 4 SD (reduction of
about 2 · 0 points), respectively, with a two-sided p value
of 0 · 05.
All economic analyses were carried out on an
intention-to-treat basis using an analysis plan finalised
prior to data analysis. Statistical tests were applied to
cost differences, but not differences in resource use, to
avoid the risk of finding significant differences by
chance, as a result of multiple-significance testing. Al-
though cost data are often skewed, as a result of small
numbers of high cost individuals, analyses compared
mean costs using standard t-tests to enable inferences to
be made about the arithmetic mean, which is a more
meaningful statistic for budgetary and planning purposes
than the median [26]. The validity of applying paramet-
ric tests was confirmed using non-parametric bootstrap-
ping [27], as recommended for the analysis of cost data
[26]. Multiple regression was used to adjust for pre-
specified baseline characteristics: gender, age, centre,
autism severity (ADOS-G modified algorithm score),
costs, parental occupation (at least one parent with a
professional or administrative occupation versus other),
parental education (at least one parent with post-16
qualifications versus other) and ethnicity (both parents
white versus other).
Full economic data were available for 94.1 % of the
sample (n = 143). Full follow-up data were missing for
only five families (3.3 %), so multiple imputation was not
considered necessary. However, the impact of missing
data was explored for the four families (2.6 %) with par-
tial data (7-month data available but not 13-month),
using the last value carried forward. This is in line with
evidence to suggest that past service use is a significant
predictor of future costs [18, 28].
The method of economic evaluation applied was cost-
effectiveness analysis, which is the most commonly
adopted approach to economic evaluation in health care
and involves the valuation of effects in a single disease-
specific outcome measure. The outcomes of two or
more interventions are then combined with their
respective costs to provide a measure of relative cost-
effectiveness that can be compared to other interven-
tions employing the same measure of effect. In the
current study, cost-effectiveness was explored in terms
of the primary outcome measure (ADOS-G) using the
net benefit approach, a framework for the analysis of un-
certainty in cost-effectiveness analysis [29]. Since PACT
was powered on the basis of a clinically meaningful im-
provement in ADOS-G score between baseline and fol-
low up of ≥4 points, the economic evaluation thus
assessed effectiveness in terms of the proportion of chil-
dren demonstrating this level of ADOS-G improvement.
A joint distribution of incremental mean costs and ef-
fects for the two groups was generated using non-
parametric bootstrapping [27]. These data were used to
explore the probability that each treatment is the opti-
mal choice, subject to a range of possible maximum
values (ceiling ratio) that a decision-maker might be
willing to pay for a 1 % increase in the proportion of
patients achieving a clinically meaningful ADOS-G
improvement. Cost-effectiveness acceptability curves
(CEAC) were generated by plotting these probabilities
for a range of possible values of the ceiling ratio [30, 31].
CEACs are a recommended decision-making approach
to dealing with uncertainty around the estimates of ex-
pected costs and effects and uncertainty regarding the
maximum cost-effectiveness ratio a decision-maker
would consider acceptable [32, 33].
Results
Participants
Figure 1 shows the CONSORT diagram for the trial. 152
children were randomised to PACT + TAU (n = 77) or
TAU (n = 75). Loss to follow-up was low (n = 6; 4 %) and
primary outcome data at final follow-up were available
for 96 % of the sample (n = 74 PACT + TAU; n = 72
TAU). Full data for the economic evaluation taking the
service perspective were available for 94 % of the sample
(n = 74 PACT + TAU; n = 69 TAU) and taking the soci-
etal perspective were available for 93 % (n = 74 PACT +
TAU; n = 68 TAU). A comparison of baseline character-
istics between those included and those missing revealed
no significant differences. There were no significant dif-
ferences in baseline characteristics between the two
groups, apart from parental education, with the PACT +
TAU families being more likely to have at least one par-
ent with post-16 qualifications (Table 1). Participants
were recruited between September 2006 and February
2008; assessments at the 13-month endpoint were car-
ried out between September 2007 and March 2009.
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Fig. 1 CONSORT flow diagram
Table 1 Baseline characteristics
PACT + TAU TAU
(n = 74) (n = 69)
Gender (female), n (%) 6 (8) 7 (10)
Age (years), median (range) 4 (2 to 5) 4 (2 to 5)
Study centre, n (%)
London 24 (32.43) 26 (37.68)
Manchester 26 (35.14) 22 (31.88)
Newcastle 24 (32.43) 21 (30.43)
Parental qualifications (at least one parent post 16), n (%)* 63 (85) 43 (62)
Parental occupation (professional/administrative), n (%) 49 (66) 42 (61)
Ethnicity (both parents white), n (%) 45 (61) 38 (55)
ADOS-G algorithm score, mean (s.d.) 19.56 (4.35) 19.38 (4.11)
Proportion of parent communications with the child that were synchronous, mean (s.d) 29.32 (12.48) 27.21 (11.18)
Total health, education and social service cost in previous six months, mean £ (s.d.) 1422 (1035) 1366 (822)
*p = 0.002
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Clinical outcomes
At the 13-month endpoint, autism symptoms were re-
duced by 3.9 points (SD 4.7) on the ADOS-G in the
PACT + TAU group and by 2.9 points (SD 3.9) in the
TAU group, representing a between-group effect size
of −0.24 (95 % CI −0.59 to 0.11). A clinically mean-
ingful improvement was in evidence for 53 % of the
PACT + TAU group compared to 41 % for TAU (odds
ratio 1.91, 95 % CI 0.94 to 3.87, p = 0.074). Treatment
effect was strong for parental synchronous response
to child (between group effect size 1.22, 95 % CI 0.85
to 1.59) and moderate for child communication initia-
tions with parent (between group effect size 0.41,
95 % CI 0.08 to 0.74).
Resource use
Resource use over 13-months is detailed in Table 2. The
cohort accessed a wide range of health, education, social
care and childcare services and attended a range of
schools and child care facilities (including nurseries,
playgroups, childminders, holiday clubs and home tu-
tors). Few differences were observed between the two
groups.
Total productivity losses were low, although larger in
the PACT + TAU group (45 versus 26 h in total over
13 months). Informal care hours were high in both
groups but lower for PACT + TAU (11.23 versus 12.44 h
per day).
Service costs
Total service costs per participant over the 13-month
follow-up are detailed in Table 3. The average cost of a
PACT session was estimated to be £264 and the total
cost of the PACT intervention was £4,105 per child, on
average; the mean number of sessions attended was 16
out of a maximum of 19.
Total health, education and social service costs were
£6,539 per child in the PACT + TAU group compared
with £2050 in TAU (mean difference £4,489, 95 % CI
£3,602 to £5,377; p < 0.001). The cost of the PACT inter-
vention accounted for the majority of the observed cost
difference. Analysis of missing data did not alter the
findings.
Table 2 Resource use per participant during the 13-month
follow-up period
PACT + TAU TAU
(n = 74) (n = 69)
Mean (s.d.) Mean (s.d.)
Speech and language therapy:
PACT sessions 15.57 (4.37) 0.00 (0.00)
NHS speech and language therapy
sessions
14.20 (15.45) 12.74 (15.28)
Other community health, education and social services:
General practitioner contacts 2.69 (2.86) 2.51 (3.26)
General practice nurse contacts 0.91 (2.05) 1.03 (1.94)
Health visitor contacts 0.84 (2.06) 0.88 (1.59)
Community paediatrician contacts 0.92 (1.04) 0.84 (1.08)
Clinical psychologist contacts 0.18 (0.56) 0.87 (3.58)
Social worker contacts 1.04 (2.24) 0.71 (1.69)
Occupational therapist contacts 1.58 (9.99) 0.78 (2.20)
Physiotherapist contacts 0.11 (0.39) 0.10 (0.46)
Dietician contacts 0.22 (0.50) 0.16 (0.53)
Educational psychologist contacts 0.38 (0.79) 0.32 (0.72)
Special Education Needs Coordinator
contacts
0.64 (2.93) 0.58 (3.74)
Portage worker contacts 1.34 (5.05) 1.87 (6.20)
Play worker contacts 0.31 (2.45) 1.91 (9.24)
Nutritionist contacts 0.03 (0.16) 0.16 (0.98)
Homeopath contacts 0.00 (0.00) 0.04 (0.36)
Osteopath contacts 0.96 (4.44) 0.32 (1.87)
Art worker contacts 0.70 (6.04) 0.00 (0.00)
Voluntary sector service contacts 4.57 (12.32) 4.19 (10.23)
Voluntary sector telephone helpline calls 1.65 (4.26) 1.06 (2.88)
Other community service contactsa 9.39 (35.31) 2.51 (6.94)
Hospital-based health services:
Hospital nights 0.09 (0.38) 0.35 (1.80)
Outpatient visits 2.38 (3.94) 1.88 (3.92)
Accident and emergency visits 0.46 (0.80) 0.39 (1.00)
Education and childcare:
Mainstream nursery weeks 25.78 (24.67) 20.42 (21.16)
Specialist nursery weeks 6.77 (16.09) 11.13 (20.74)
Mainstream playgroup weeks 3.61 (9.33) 3.00 (14.06)
Specialist playgroup weeks 5.09 (13.02) 7.14 (16.78)
Mainstream school weeks 13.07 (19.59) 16.59 (23.29)
Specialist school weeks 8.95 (17.67) 8.16 (18.95)
Holiday club weeks 0.39 (3.37) 0.19 (1.45)
Live in childcare weeks 0.16 (1.39) 0.00 (0.00)
Home tutor weeks 1.19 (6.78) 0.00 (0.00)
Childminder weeks 3.58 (13.24) 3.38 (10.84)
Table 2 Resource use per participant during the 13-month
follow-up period (Continued)
Parental productivity losses and informal care:
Productivity loss total hours 45.07 (76.36) 25.47 (57.89)
Informal care hours per day 11.23 (7.18) 12.44 (7.00)
aIncludes dentist, community autism specialist, family support worker, home
care worker, audiology, podiatrist, ophthalmology, walk-in centre, podiatrist
Byford et al. BMC Psychiatry  (2015) 15:316 Page 6 of 13
Societal costs
Broader societal costs, including the cost of schooling
and childcare and parental costs (out-of-pocket expend-
iture, productivity losses and informal care), are reported
in Table 4. Lower informal care costs in the PACT +
TAU group reduced the cost difference between the
groups to a non-significant amount (mean difference
£1,385; 95 % CI –£8,468 to £11,239).
Cost-effectiveness analysis
In terms of service costs (health, social care and educa-
tion), Fig. 2 shows the bootstrapped replications for in-
cremental cost and effectiveness and demonstrates that
PACT + TAU is more costly than TAU for all replica-
tions (points above the x-axis) and is associated with
better outcomes for the majority of replications (points
to the right of the y-axis). The CEAC in Fig. 3 illustrates
the associated uncertainty. At low levels of willingness
to pay per child for a unit improvement in the propor-
tion of children who demonstrate a clinically meaningful
ADOS-G improvement, there is a greater probability of
TAU being the more cost-effective intervention. At will-
ingness to pay levels of £265 and above, however, there
is a greater probability of PACT + TAU being the more
cost-effective option.
In terms of societal costs, results were similar but
more favourable for PACT + TAU due to reductions in
the cost difference between the groups. Figure 4 demon-
strates that PACT + TAU is more costly for approxi-
mately 60 % of the replications (compared to 100 %
when considering only service costs) and is associated
with better outcomes for the majority of replications.
The CEAC in Fig. 5, shows PACT + TAU has a higher
probability of being cost-effective than TAU if society is
willing to pay £100 or more per child for a unit improve-
ment in the proportion of children who demonstrate a
clinically meaningful ADOS-G improvement.
Treatment effects in the PACT trial were positive for a
number of targeted proximal outcomes, particularly par-
ental synchronous responses to the child, also found to
be positive in our pilot study [25]. This suggests the
PACT therapy was more successful at improving par-
ent–child social communication than reducing autism
symptoms [11]. This finding was considered further in a
secondary, exploratory cost-effectiveness analysis.
Results using parental synchronous responses and
total service costs generated similar results to the pri-
mary outcome measure, as demonstrated in Figs. 6 and
7. The scatter-plot in Fig. 6 illustrates that PACT + TAU
is more costly (above x-axis) and more effective (right of
y-axis) than TAU for all replications. Figure 7 shows
TAU having a higher probability of being cost-effective
at low levels of willingness to pay but PACT + TAU be-
ing more likely to be cost-effective at willingness to pay
Table 3 Total cost of services per participant over the 13-month follow-up period (£), including sensitivity analysis
PACT + TAU TAU
n Mean (s.d.) n Mean (s.d) Difference (95 % CI) p-value*
PACT 74 4105 (2122) 69 0 (0) 4105 (3599 to 4610) 0.000
NHS speech and language therapy 74 568 (618) 69 510 (611) 59 (−145 to 262) 0.555
Other community health, education and social services 74 1200 (2026) 69 1000 (1187) 200 (−355 to 754) 0.612
Medication 74 321 (1646) 69 110 (422) 210 (−193to 614) 0.434
Hospital-based health services 74 392 (651) 69 430 (930) −38 (−302 to 226) 0.613
Total health, education and social services 74 6539 (3378) 69 2050 (1633) 4489 (3602 to 5377) 0.000
Last observation carried forward for missing cases 74 6539 (3378) 73 2213 (1850) 4326 (3436 to 5215) 0.000
*Adjusted for gender, age, centre, baseline ADOS-G score, baseline total costs, parental occupation, parental education and ethnicity
Table 4 Total societal cost per participant over the 13-month follow-up period (£)
PACT + TAU TAU Difference (95 % CI) p-value*
(n = 74) (n = 68)
Mean (s.d.) Mean (s.d.)
Total health, education and social services 6539 (3378) 2050 (1633) 4489 (3534to 5377) 0.000
Education and childcare 3743 (1451) 3578 (1462) 199 (−417 to 1004) 0.366
Parental out-of-pocket expenditure 1146 (2079) 788 (1019) 358 (−189 to 906) 0.149
Parental productivity losses 484 (837) 338 (918) 146 (−144 to 437) 0.621
Parental informal care 46007 (28722) 49814 (28970) −3808 (−13350 to 5735) 0.459
Total societal cost 57919 (30157) 56534 (29375) 1385 (−8468 to 11239) 0.788
*Adjusted for gender, age, centre, baseline ADOS-G score, baseline total costs, parental occupation, parental education and ethnicity
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of £300 or above per 1 % increase in the proportion of
parental communications with the child that were
synchronous.
Discussion
The Pre-school Autism Communication Trial found a
small group difference in autism symptoms in favour of
the PACT intervention and concluded that it was not
possible to recommend the addition of the PACT inter-
vention to TAU for the reduction of autism symptoms
[11]. However, this conclusion did not take into consid-
eration cost or cost-effectiveness implications, without
which it is not possible to determine whether the PACT
intervention is an efficient use of resources.
Resource use and cost
In terms of service use, few differences were observed
between the two groups, with the exception of the PACT
intervention, resulting in a statistically significant differ-
ence in total service cost that was driven by the cost of
the PACT intervention. Thus the PACT intervention
neither increased nor decreased participants’ use of
other health, social or education services. This result
contrasts with cost-savings demonstrated for EIBI in
Fig. 2 Cost-effectiveness plane using total service costs and ADOS-G score. Cost-effectiveness plane showing the bootstrapped, adjusted differences in
total service costs and effects using the proportion of children demonstrating a clinically meaningful improvement in ADOS-G score
Fig. 3 Cost-effectiveness acceptability curve using total service costs and ADOS-G score. Cost-effectiveness acceptability curve showing the probability
that PACT + TAU is more cost-effective than TAU alone in terms of total service costs and proportion of children demonstrating a clinically meaningful
improvement in ADOS-G score
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previous studies [7–10]. However, these studies all in-
volved estimation of savings based on published evi-
dence of the effectiveness of EIBI, and assumptions
relating to the impact of EIBI on the need for special
education, compared to no intervention. The relevance
of these results to the UK is currently unknown and, as
noted by Motiwala and colleagues [9], uncertainty sur-
rounding the efficacy of EIBI suggests the need for fur-
ther evaluation within a rigorous, randomised controlled
design.
The inclusion of wider societal costs reduced the cost
difference to a non-significant amount as a result of
lower rates of informal care in the PACT + TAU group.
However, confidence intervals were wide due to substan-
tial variation in informal care hours, so these results
should be interpreted cautiously. From a therapeutic
point of view, there is some logic to the PACT + TAU
group’s lower informal care estimates, since the PACT
intervention aims to help parents feel more confident in
recognising and meeting their child’s needs. Despite this,
reported rates of informal care were large for both
groups (over 11 h per day on average), highlighting the
substantial burden placed on families of young children
with autism. These rates are higher than in a previous
Fig. 4 Cost-effectiveness plane using total societal costs and ADOS-G score. Cost effectiveness plane showing the bootstrapped, adjusted differences
in total societal costs and effects using the proportion of children demonstrating a clinically meaningful improvement in ADOS-G score
Fig. 5 Cost-effectiveness acceptability curve using total societal costs and ADOS-G score. Cost-effectiveness acceptability curve showing the probability
that PACT + TAU is more cost-effective than TAU alone in terms of total societal costs and proportion of children demonstrating a clinically meaningful
improvement in ADOS-G score
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study [34], which reported a mean of 8.6 h per day using
similar methods. However, those findings were based on
a sample of only nine children who were older than the
PACT participants (mean age 7.8 versus 3.7 years).
Productivity losses were low in both groups. This may
be because the majority of the children were in some
form of education for some or all of the school day.
However, these results exclude decisions taken by par-
ents to stop working in order to support their child prior
to the start of the trial, so the full extent of productivity
losses is unknown.
Mean costs per child hide substantial variation,
also evident at baseline [6]. Total service costs over
13-months ranged from £0 to £229 per week, whilst ser-
vice costs plus education costs (all statutory provision)
ranged from £41 to £322 per week. This suggests that after
diagnosis, a proportion of young children with autism are
failing to be provided with or failing to access available
Fig. 6 Cost-effectiveness plane using total service costs and parent synchrony. Cost effectiveness plane showing the bootstrapped, adjusted differences in
total service costs and effects using the proportion of parent communications with the child that were synchronous
Fig. 7 Cost-effectiveness acceptability curve using total service costs and parent synchrony. Cost-effectiveness acceptability curve showing the
probability that PACT + TAU is more cost-effective than TAU alone in terms of total service costs and proportion of parent communications with
the child that were synchronous
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services and education facilities, perhaps because a need
for additional support was not identified.
Cost-effectiveness
Assessment of costs and outcomes independently sug-
gests that PACT is associated with significantly greater
costs and no significant difference in outcome, and thus
should not be recommended as a cost-effective addition
to TAU. Exploration of cost-effectiveness and the uncer-
tainty associated with the cost and effectiveness data
suggests that the addition of PACT to TAU would only
have a higher probability of being cost-effective com-
pared to TAU alone if society is willing to pay extra for
improvements in outcome. In other words, adding the
PACT intervention to TAU generates additional benefits
compared to TAU alone, but at a price. Results were
similar whether autism symptoms or parental synchrony
are the measure of effect. These results are relevant to
children with core autism and may not be generalizable
to children with broad autism spectrum disorder.
Limitations
There is no currently available societal value for a unit
improvement in ADOS-G score, making it difficult to
decide whether PACT should be recommended on the
grounds of cost-effectiveness. The economists’ solution
to such trade-offs (one intervention more effective, but
more costly than another) is to use generic measures of
health-related quality of life capable of generating such
indicators as the quality adjusted life year (QALY) [35,
36]. These provide a common measure of output allow-
ing comparisons to be made between diverse interven-
tions and can be associated with societal values of
willingness to pay to support decision making. The
PACT trial was unable to include a generic outcome
measure because, until recently, all available measures
were developed for application to adult populations.
Although some measures have now been adapted or de-
veloped for younger populations [37–39], these are rec-
ommended for children aged 7 years and over and thus
are not suitable for a pre-school population. Nor have
they been validated for use with children with autism,
some of whom may be non-verbal. In the absence of a
generic measure, it is up to policy-makers and service
commissioners to decide whether the PACT interven-
tion is worth paying for, given the levels of effectiveness
generated. In addition, future studies should consider
the inclusion of generic measures of quality of life for
children and the use of proxy respondents.
This study is also limited by the retrospective, self-
report nature of informal care, with evidence suggesting
that self-reported informal care hours are over-inflated
compared to prospective diaries [34]. This reduces the
reliance we can have on the informal care data, which is
notoriously difficult to measure accurately [40, 41]. In
order to minimise reporting problems, responses were
elicited from respondents in interview with the research
assessors, allowing respondents the opportunity to ask
questions if they were having difficulties completing the
measure. Whilst there were still some problematic re-
sponses (for example, respondents reporting greater than
24 h a day), feedback from the interviewers provided a
relatively good understanding of the difficulties (respon-
dents feeling that they were supervising their children
24 h a day, alongside all other support provided), allow-
ing the data to be adjusted to reduce the impact of this
problem. Perhaps most importantly, however, these re-
sults highlight the need to explore this area in more de-
tail and using more sophisticated methods, in order to
confirm the findings.
Conclusions
The addition of the PACT intervention to treatment as
usual for children aged between 2 years and 4 years
11 months and meeting criteria for autism generated im-
provements in the severity of autism symptoms and in
parental synchrony, but these improvements were not
statistically significant, they required a substantial invest-
ment of health service resources and they did not gener-
ate cost-savings elsewhere in the healthcare system or in
the education or social care systems. Although there was
evidence of reductions in the burden on parents in the
PACT group, which partly offset the cost of the PACT
intervention, the cost and effectiveness results presented
do not support the cost-effectiveness of PACT + TAU
compared to TAU alone. Further research is needed to
build a better understanding of the informal care impli-
cations of supporting young children autism and the val-
idity of generic measures of outcome to better support
resource allocation decisions in the future.
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